Ozempic vs Lantus and Ozempic 1 mg vs 2 mg 1 SUSTAIN 4: vs study-titrated Lantus 1,9 In insulin-nave adult patients with type 2 diabetes on metformin sulfonylurea Secondary endpoint: mean change in body weight from baseline to Week 30 Mean baseline: 206 lb SUSTAIN FORTE: Ozempic 1 mg vs 2 mg 1,4,8 In adult patients with type 2 diabetes on metformin sulfonylurea Secondary endpoint: mean change in body weight from baseline to Week 40 Mean baseline: 219 lb Results based on sensitivity analyses of retrieved dropout population
Evidence comes from: Clinical trials Case reports Adverse event databases Retrospective studies Each type of investigation provides useful insight, but is also associated with important limitations that we must consider
For the foundational comparison context, see GHK-Cu vs GLOW Blend: Which Has the Most Research Support
Used commonly by healthcare professionals, i.e., doctors, physicians, and in medical care facilities, a J-Code simplifies the medical billing process and helps them obtain full reimbursement against their services